Geetha Davis, MD
Ophthalmology · Columbia, MONPI 1265638001
Payments from drug & device makers
Across 40 payments — averaging $34.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$864
- Carl Zeiss Meditec USA, Inc.$265
- NEW World Medical,inc.$88
- Regeneron Healthcare Solutions, Inc.$74
- Novartis$24
- Aerie Pharmaceuticals, Inc.$19
- plus $31 from 2 others
What the payments were for
- Food & beverage$1,365100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 26 | $864 |
| Carl Zeiss Meditec USA, Inc. | 7 | $265 |
| NEW World Medical,inc. | 2 | $88 |
| Regeneron Healthcare Solutions, Inc. | 1 | $74 |
| Novartis | 1 | $24 |
| Aerie Pharmaceuticals, Inc. | 1 | $19 |
| Iridex Corporation | 1 | $17 |
| Carl Zeiss Meditec Cataract Technology Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QUATERA 700$126
- Hydrus Microstent$101
- Voyager DSLT$101
How this compares
$1,365 in reported general payments places this provider in the 45th percentile of 286 ophthalmology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 31 | $26,392 |
| LumiganBimatoprost | 18 | $10,101 |
| Latanoprost | 222 | $4,261 |
| Travoprost | 20 | $3,597 |
| Loteprednol Etabonate | 12 | $2,846 |
| Prednisolone Acetate | 43 | $1,761 |
| Methazolamide | 11 | $1,212 |
| Brimonidine Tartrate | 23 | $1,124 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 52 | $1,028 |
| Timolol Maleate | 73 | $584 |
| Doxycycline Hyclate | 16 | $461 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Columbia
- Jella AnColumbia$236K
- Mai PhamColumbia$21K
- John McCannColumbia$8K
- Nancy HolekampChesterfield$2.7M
- Steven SilversteinKansas City$1.6M
- Joseph TauberKansas City$1.3M
- Steven CouchSaint Louis$1.2M
- Andrew MoyesKansas City$1.1M
- Ranjan MalhotraSaint Louis$964K
- Navin TekwaniSaint Louis$957K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.